Holly Pederson, MD, and Elisha Hughes, PhD, discuss the findings and implications of a study evaluating risk of triple-negative breast cancer for Black women presented at the 2024 ASCO Annual Meeting.
Holly Pederson, MD
Advertisement
Holly Pederson, MD, is part of the medical breast team at Cleveland Clinic and professor of medicine at Cleveland Clinic Lerner College of Medicine.
Articles by Holly Pederson, MD
Advertisement
Latest Updated Articles
Genetic Risk Score Revolutionizes TNBC Prediction in Black WomenPublished: June 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
